Zhonghua Yi Xue Za Zhi
One supplement (SNDS #276224, filed June 16, 2023) resulted in a Notice of Compliance issued November 1, 2023, with modifications to the Warnings and Precautions and Adverse Reactions sections of the product monograph [Source: dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00629]
The company's program includes nutrition logging and coaching, activity tracking, sleep management, and stress and mental health tools and virtual care
Taste scores subsequently declined at 20% addition, with sample B rated as the most preferred formulation overall
The influence of drug-like concepts on decision-making in medicinal chemistry
People with certain health conditions such as liver disease, kidney disease, or those who are at a high risk of bleeding should exercise caution when using Astaxanthin + Lutein + Omega 3 Fatty Acid + Zeaxanthin